International guidelines for the selection of lung transplant candidates

Heart and Lung

Volumn 27, Issue 4, 1998, Pages 223-229

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGENITAL HEART DISEASE; CYSTIC FIBROSIS; EISENMENGER COMPLEX; FIBROSING ALVEOLITIS; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; NOTE; PATIENT REFERRAL; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC DISEASE; TREATMENT CONTRAINDICATION; ARTICLE; STANDARD; UNITED STATES;

HUMANS; LUNG TRANSPLANTATION; PATIENT SELECTION; UNITED STATES;

EID: 0032109619     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90033-4     Document Type: Note

References (35)

1. Hosenpud, JD, Bennett, LE, Keck, BM, et al. The registry of the International Society for Heart and Lung Transplantation: fourteenth official report—1997. J Heart Lung Transplant 16 (1997), 691–712.
2. UNOS, Division of Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Dept of Health and Human Services, 1996 annual report of the U.S. scientific registry for transplant recipients and the organ procurement and transplantation network—transplant data 1988–1995, 1996, UNOS, Richmond, Va.
3. UNOS, Division of Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Dept of Health and Human Services, 1996 annual report of the U.S. scientific registry for transplant recipients and the organ procurement and transplantation network—transplant data 1988–1995, 1996, U.S. Dept of Health and Human Services, Rockville, Md.
4. Aris, RM, Neuringer, IP, Weiner, MA, et al. Severe osteoporosis before and after lung transplantation. Chest 109 (1996), 1176–1183.
5. Shafers, H-J, Wagner, TOF, Demertzis, S, et al. Preoperative corticosteroids: a contraindication to lung transplantation?. Chest 102 (1992), 1522–1525.
6. Sharples, L, Hathaway, T, Dennis, C, et al. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. I Heart Lung Transplant 12 (1993), 669–674.
7. Grady, KL, Costanzo, MR, Fisher, S, Koch, D, Preoperative obesity is associated with decreased survival after heart transplantation. J Heart Lung Transplant 15 (1996), 863–871.
8. Zaltzman, IS, Pei, Y, Maurer, I, et al. Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation 54 (1992), 875–878.
9. Levine, SM, Anzueto, A, Peters, JI, et al. Single lung transplantation in patients with systemic disease. Chest 105 (1994), 837–841.
10. Cooper, ID, Patterson, GA, Sundaresan, RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 112 (1996), 1319–1330.
11. McKenna, RJ Jr, Brenner, M, Gelb, AF, et al. A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. I Thorac Cardiovasc Surg 111 (1996), 317–322.
12. Fein, AM, Braman, SS, Casaburi, R, et al. Lung volume reduction surgery: official statement of the American Thoracic Society. Am J Respir Crit Care Med 154 (1996), 1151–1152.
13. Anthonisen, NR, Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Resp Dis 140 (1989), S95–S99 (3pt2).
14. Gray-Donald, K, Gibbons, L, Shapiro, SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153 (1996), 961–966.
15. Seersholm, N, Dirksen, A, Kok-lensen, A, Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency. Eur Resp J 7 (1994), 1985–1987.
16. Bando, K, Paradis, IL, Keenan, RJ, et al. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 14 (1995), 692–698.
17. Smith, CM, Patient selection, evaluation and preoperative management for lung transplant candidates. Clin Chest Med 18 (1997), 183–197.
18. Connors, AF Jr, Dawson, NV, Thomas, C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am I Respir Crit Care Med 154 (1996), 959–967.
19. Snell, GI, de Hoyos, A, Krajden, M, et al. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 105 (1994), 310–312.
20. Aris, RM, Gilligan, PH, Neuringer, IP, et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Resp Crit Care Med 155 (1997), 1699–1704.
21. Microbiology and infectious diseases in cystic fibrosis, 5th ed. From North American Cystic Fibrosis Foundation Concepts in Care Consensus Conference, 5, 1994, 1–25.
22. Kerem, E, Reisman, J, Corey, M, et al. Prediction of mortality in patients with cystic fibrosis. N Eng I Med 326 (1992), 1187–1191.
23. Dodge, JA, Morison, S, Lewis, PA, et al. Cystic fibrosis in the United Kingdom, 1968–1988: incidence, population and survival. Paediatric Perinatal Epidemiol 7 (1993), 157–166.
24. Turner-Warwick, M, Burrows, B, Johnson, A, Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 35 (1980), 593–599.
25. Schwartz, DA, Helmers, RA, Galvin, JR, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149 (1994), 450–454.
26. Hanson, D, Winterbauer, RH, Kirtland, SH, et al. Changes in pulmonary function test results after one year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 108 (1995), 305–310.
27. Raghu, G, Depaso, WJ, Cain, K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective, double-blind, randomized, placebocontrolled trial. Am Rev Respir Dis 144 (1991), 291–296.
28. D'Alonzo, GE, Barst, RI, Ayers, SM, et al. Survival in patients with primary pulmonary hypertension. Ann Intern Med 115 (1991), 343–349.
29. Barst, RI, Rubin, LJ, Long, WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl I Med 334 (1996), 296–301.
30. Kerstein, D, Levy, PS, Hsu, DT, et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 91 (1995), 2028–2035.
31. Fedullo, PF, Auger, WR, Channick, RN, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 16 (1995), 353–374.
32. Hopkins, WE, Ochoa, LL, Richardson, GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. I Heart Lung Transplant 15 (1996), 100–105.
33. Mandell, MS, Groves, BM, Pulmonary hypertension in chronic liver disease. Clin Chest Med 16 (1996), 17–33.
34. Wallwork, J, Calne, RY, Williams, R, Transplantation of liver, heart and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet 2:8552 (1987), 182–185.
35. Armitage, JM, Kurland, G, Michaels, M, et al. Critical issues in pediatric lung transplantation. J Thorac Cardiovasc Surg 109 (1995), 60–64.